FTC to refund $1.25 million to those tricked by LASIK surgery chain. Here's how to file a claim
Nearly 160,000 Americans could be eligible for a refund if misled by the nation's biggest LASIK chain, which advertised the surgery for as little $300 an eye, even though most consumers would not qualify for that price, the Federal Trade Commission said on Tuesday.
Ohio-based LCA-Vision, operating business under the names LasikPlus and Joffe MediCenter, paid $1.25 million to settle claims that it used deceptive bait-and-switch advertising to trick people into thinking they could have their vision corrected for less than $300, according to the FTC.
"Many people wasted their time at LASIK consultations only to learn that the surgery would cost much more than they expected," the agency stated.
Only 6.5% of those who came in for a consultation were eligible for the advertised promotional price for both eyes, which required having near-normal vision, or good enough eye sight to drive without glasses. Everyone else was typically given a price of between $1,800 and $2,295 per eye, the FTC said.
In addition, some ads neglected to state upfront that the advertised price was per eye.
How to file a LASIK claim
The commission is sending notices to 159,711 consumers who could be eligible for a payment, provided they visited a LasikPlus or Joffe MediCenter facility for a LASIK consultation but declined surgery after learning the real price.
Those who get an email or letter with a claim identification number can then apply for a payment online by May 20, 2024, at www.ftc.gov/lasik.
The FTC expects to mail payments in 2024 but does not yet have a specific mailing date.
Folks who need help with their claims can call the administrator at 1-877-871-0504.
Payment amounts will depend on several factors, including how many people file a claim.
Kate GibsonKate Gibson is a reporter for CBS MoneyWatch in New York.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
